Literature DB >> 21084476

Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion gene.

Makoto Ohashi1, Nina Orlova, Carol Quink, Fred Wang.   

Abstract

Rhesus macaques are naturally infected with a gammaherpesvirus which is in the same lymphocryptovirus (LCV) genus as and closely related to Epstein-Barr virus (EBV). The rhesus macaque LCV (rhLCV) contains a repertoire of genes identical to that of EBV, and experimental rhLCV infection of naive rhesus macaques accurately models acute and persistent EBV infection of humans. We cloned the LCL8664 rhLCV strain as a bacterial artificial chromosome to create recombinant rhLCV for investigation in this animal model system. A recombinant rhLCV (clone 16 rhLCV) carrying a mutation in the putative immune evasion gene rhBARF1 was created along with a rescued wild-type (rWT) rhLCV in which the rhBARF1 open reading frame (ORF) was repaired. The rWT rhLCV molecular clone demonstrated viral replication and B-cell immortalization properties comparable to those of the naturally derived LCL8664 rhLCV. Qualitatively, clone 16 rhLCV carrying a mutated rhBARF1 was competent for viral replication and B-cell immortalization, but quantitative assays showed that clone 16 rhLCV immortalized B cells less efficiently than LCL8664 and rWT rhLCV. Functional studies showed that rhBARF1 could block CSF-1 cytokine signaling as well as EBV BARF1, whereas the truncated rhBARF1 from clone 16 rhLCV was a loss-of-function mutant. These recombinant rhLCV can be used in the rhesus macaque animal model system to better understand how a putative viral immune evasion gene contributes to the pathogenesis of acute and persistent EBV infection. The development of a genetic system for making recombinant rhLCV constitutes a major advance in the study of EBV pathogenesis in the rhesus macaque animal model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084476      PMCID: PMC3020515          DOI: 10.1128/JVI.01411-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Cloning of the full-length rhesus cytomegalovirus genome as an infectious and self-excisable bacterial artificial chromosome for analysis of viral pathogenesis.

Authors:  W L William Chang; Peter A Barry
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

2.  Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptoviruses.

Authors:  R Peng; A V Gordadze; E M Fuentes Pananá; F Wang; J Zong; G S Hayward; J Tan; P D Ling
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.

Authors:  Pierre Rivailler; Young-Gyu Cho; Fred Wang
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  N-terminal domain of BARF1 gene encoded by Epstein-Barr virus is essential for malignant transformation of rodent fibroblasts and activation of BCL-2.

Authors:  W Sheng; G Decaussin; S Sumner; T Ooka
Journal:  Oncogene       Date:  2001-03-08       Impact factor: 9.867

6.  Complete nucleotide sequence of the rhesus lymphocryptovirus: genetic validation for an Epstein-Barr virus animal model.

Authors:  Pierre Rivailler; Hua Jiang; Young-gyu Cho; Carol Quink; Fred Wang
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

7.  Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies.

Authors:  G Decaussin; F Sbih-Lammali; M de Turenne-Tessier; A Bouguermouh; T Ooka
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

8.  Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system.

Authors:  Teru Kanda; Misako Yajima; Nazmul Ahsan; Mika Tanaka; Kenzo Takada
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 9.  Herpesvirus genetics has come of age.

Authors:  Markus Wagner; Zsolt Ruzsics; Ulrich H Koszinowski
Journal:  Trends Microbiol       Date:  2002-07       Impact factor: 17.079

10.  Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.

Authors:  Pierre Rivailler; Angela Carville; Amitinder Kaur; Pasupuleti Rao; Carol Quink; Jeffery L Kutok; Susan Westmoreland; Sherry Klumpp; Meredith Simon; Jon C Aster; Fred Wang
Journal:  Blood       Date:  2004-05-18       Impact factor: 22.113

View more
  11 in total

Review 1.  Animal models of tumorigenic herpesviruses--an update.

Authors:  Dirk P Dittmer; Blossom Damania; Sang-Hoon Sin
Journal:  Curr Opin Virol       Date:  2015-10       Impact factor: 7.090

2.  Multipronged attenuation of macrophage-colony stimulating factor signaling by Epstein-Barr virus BARF1.

Authors:  Ann Hye-Ryong Shim; Rhoda Ahn Chang; Xiaoyan Chen; Richard Longnecker; Xiaolin He
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

Review 3.  Nonhuman primate models of human viral infections.

Authors:  Jacob D Estes; Scott W Wong; Jason M Brenchley
Journal:  Nat Rev Immunol       Date:  2018-06       Impact factor: 53.106

4.  Allosteric competitive inactivation of hematopoietic CSF-1 signaling by the viral decoy receptor BARF1.

Authors:  Jonathan Elegheert; Nathalie Bracke; Philippe Pouliot; Irina Gutsche; Alexander V Shkumatov; Nicolas Tarbouriech; Kenneth Verstraete; Anaïs Bekaert; Wim P Burmeister; Dmitri I Svergun; Bart N Lambrecht; Bjorn Vergauwen; Savvas N Savvides
Journal:  Nat Struct Mol Biol       Date:  2012-08-19       Impact factor: 15.369

Review 5.  Nonhuman primate models for Epstein-Barr virus infection.

Authors:  Fred Wang
Journal:  Curr Opin Virol       Date:  2013-04-03       Impact factor: 7.090

6.  Epstein-Barr Virus gp350 Can Functionally Replace the Rhesus Lymphocryptovirus Major Membrane Glycoprotein and Does Not Restrict Infection of Rhesus Macaques.

Authors:  Marissa Herrman; Janine Mühe; Carol Quink; Fred Wang
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

Review 7.  Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences.

Authors:  B Karsten Tischer; Benedikt B Kaufer
Journal:  J Biomed Biotechnol       Date:  2012-02-23

Review 8.  BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator.

Authors:  Eveline K Hoebe; Tessa Y S Le Large; Astrid E Greijer; Jaap M Middeldorp
Journal:  Rev Med Virol       Date:  2013-08-31       Impact factor: 6.989

9.  Epstein-Barr Virus Gene BARF1 Expression is Regulated by the Epithelial Differentiation Factor ΔNp63α in Undifferentiated Nasopharyngeal Carcinoma.

Authors:  Eveline Hoebe; Coral Wille; Stacy Hagemeier; Shannon Kenney; Astrid Greijer; Jaap Middeldorp
Journal:  Cancers (Basel)       Date:  2018-03-17       Impact factor: 6.639

10.  An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infection.

Authors:  Makoto Ohashi; Mark H Fogg; Nina Orlova; Carol Quink; Fred Wang
Journal:  PLoS Pathog       Date:  2012-12-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.